Clinical Trials
1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Study of Awareness and Detection of Familial Hypercholesterolemia
- Conditions
- Hypercholesterolemia
- First Posted Date
- 2013-10-10
- Last Posted Date
- 2023-11-27
- Lead Sponsor
- The Familial Hypercholesterolemia Foundation
- Target Recruit Count
- 5000
- Registration Number
- NCT01960244
- Locations
- 🇺🇸
Stanford Center for Inherited Cardiovascular Diseases, Palo Alto, California, United States
News
VESALIUS-REAL Study Reveals Critical Gaps in Cardiovascular Care Despite Available Treatments
The VESALIUS-REAL study of 278,000 high-risk patients found 70% did not receive lipid-lowering therapy after heart attacks or strokes, and 88% had no treatment intensification within a year.
Elevated Lipoprotein(a) Linked to Higher Risk of Recurrent Cardiovascular Events in Landmark Study
A landmark study of over 273,000 individuals with atherosclerotic cardiovascular disease found that every increase in lipoprotein(a) levels is associated with higher risk of recurrent cardiovascular events.
Family Heart Foundation Launches Free At-Home Lipid Screening Program to Combat Cardiovascular Disease
The Family Heart Foundation has introduced Cholesterol Connect, offering free at-home lipid screening and personalized support to address cardiovascular disease, which claims one American life every 33 seconds.